These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31014563)

  • 1. Corrigendum to "Synthesis and SAR of novel capsazepine analogs with significant anti-cancer effects in multiple cancer types" [Bioorg. Med. Chem. 27 (1) (2019) 208-215].
    De La Chapa J; Valdez M; Ruiz F; Gonzales K; Mitchell W; McHardy SF; Hart MJ; Polusani SR; Gonzales CB
    Bioorg Med Chem; 2019 Jun; 27(11):2280. PubMed ID: 31014563
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "Metal-assisted synthesis of unsymmetrical magnolol and honokiol analogs and their biological assessment as GABA
    Rycek L; Puthenkalam R; Schnürch M; Ernst M; Mihovilovic MD
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1811. PubMed ID: 28718421
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents" [Bioorg. Med. Chem. 19 (2011) 5409-5419].
    Kumar A; Tripathi VD; Kumar P; Gupta LP; Akanksha ; Trivedi R; Bid H; Nayak VL; Siddiqui JA; Chakravarti B; Saxena R; Dwivedi A; Siddiquee MI; Siddiqui U; Konwar R; Chattopadhyay N
    Bioorg Med Chem; 2019 Sep; 27(17):3960-3961. PubMed ID: 31345744
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary to "The structure of McN-5652" [Bioorg. Med. Chem. 9 (2001) 2105] and to the corrigendum to "The structure of McN-5652" [Bioorg. Med. Chem. 10 (2002) 3368].
    Maryanoff BE
    Bioorg Med Chem; 2002 Oct; 10(10):3367. PubMed ID: 12150884
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Challenges in the development of an M
    Tarr JC; Wood MR; Noetzel MJ; Melancon BJ; Lamsal A; Luscombe VB; Rodriguez AL; Byers FW; Chang S; Cho HP; Engers DW; Jones CK; Niswender CM; Wood MW; Brandon NJ; Duggan ME; Jeffrey Conn P; Bridges TM; Lindsley CW
    Bioorg Med Chem Lett; 2018 Sep; 28(17):3014. PubMed ID: 30076050
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to 'Novel carbocyclic nucleoside analogs suppress glomerular mesangial cells proliferation and matrix protein accumulation through ROS-dependent mechanism in the diabetic milieu. II. Acylhydrazone-functionalized pyrimidines' [Bioorg. Med. Chem. Lett. 26 (2016) 1020-1024].
    Bouhadir KH; Koubeissi A; Mohsen FA; Diab El-Harakeh M; Cheaib R; Younes J; Azzi G; Eid AA
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2439. PubMed ID: 31262558
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity" [Bioorg. Med. Chem. 25 (2017) 1524-1532].
    Paraskevopoulos G; Monteiro S; Vosátka R; Krátký M; Navrátilová L; Trejtnar F; Stolaříková J; Vinšová J
    Bioorg Med Chem; 2017 Apr; 25(8):2530. PubMed ID: 28285926
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Synthesis and biological evaluations of new nitric oxide-anti-inflammatory drug hybrids" [Bioorg Med Chem Lett (2017) 4358-4369].
    Abdelall EKA; Abdelhamid AO; Azouz AA
    Bioorg Med Chem Lett; 2018 Feb; 28(4):839. PubMed ID: 29395977
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Reengineered tricyclic anti-cancer agents" [Bioorg. Med. Chem. 23 (2015) 6528-6534].
    Kastrinsky DB; Sangodkar J; Zaware N; McClinch K; Farrington CC; Giannini HM; Izadmehr S; Dhawan NS; Narla G; Ohlmeyer M
    Bioorg Med Chem; 2015 Dec; 23(23):7487. PubMed ID: 28290285
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870].
    Arslan T; Türkoğlu EA; Şentürk M; Supuran CT
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3944. PubMed ID: 28705642
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].
    Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309
    [No Abstract]   [Full Text] [Related]  

  • 12. Retraction notice to 'Corrigendum to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis"' [Bioorg. Med. Chem. 20 (2012) 5668-5668].
    Bioorg Med Chem; 2014 Dec; 22(23):6726. PubMed ID: 25756091
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606].
    Li J; Li D; Xu Y; Guo Z; Liu X; Yang H; Wu L; Wang L
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3822. PubMed ID: 30385163
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction" [Bioorg. Med. Chem. Lett. 26 (2016) 2695-2700].
    Jadhav GR; Sinha S; Chhabra M; Paira P
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4154-4155. PubMed ID: 27396504
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5 [Bioorg Med Chem Lett 28 (17) (2018) 2930-2938]".
    Khathi SP; Chandrasekaran B; Karunanidhi S; Tham CL; Kozielski F; Sayyad N; Karpoormath R
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3489. PubMed ID: 30279037
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives" [Bioorg. Med. Chem. Lett. 28 (14) (2018) 2481-2484].
    Derabli C; Boualia I; Abdelwahab AB; Boulcina R; Bensouici C; Kirsch G; Debache A
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3129. PubMed ID: 30119958
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3" [Bioorg. Med. Chem. 23 (2015) 4871-4883].
    Nakajima Y; Inoue T; Nakai K; Mukoyoshi K; Hamaguchi H; Hatanaka K; Sasaki H; Tanaka A; Takahashi F; Kunikawa S; Usuda H; Moritomo A; Higashi Y; Inami M; Shirakami S
    Bioorg Med Chem; 2017 May; 25(10):2813. PubMed ID: 28366269
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3" [Bioorg. Med. Chem. 23 (2015) 4871-4883].
    Nakajima Y; Inoue T; Nakai K; Mukoyoshi K; Hamaguchi H; Hatanaka K; Sasaki H; Tanaka A; Takahashi F; Kunikawa S; Usuda H; Moritomo A; Higashi Y; Inami M; Shirakami S
    Bioorg Med Chem; 2016 Sep; 24(18):4517. PubMed ID: 27544046
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Rotenoisin A is a novel anti-adipogenic compound" [Bioorg. Med. Chem. Lett. 29 (2018) 89-96].
    Cho HH; Park HS; Jang SH; Won C; Kim HD; Kim TH; Cho JH
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127295. PubMed ID: 32571641
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents" [Bioorg. Med. Chem. Lett. 18 (2008) 6054-6057].
    Sekhar KVGC; Rao VS; Devambatla RKV; Kumar MMK
    Bioorg Med Chem Lett; 2017 May; 27(9):2081. PubMed ID: 28336140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.